213 related articles for article (PubMed ID: 1843713)
1. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
[TBL] [Abstract][Full Text] [Related]
2. [Effects of adrenergic beta 2 agonists by oral route on theophylline blood levels].
Terra Filho M; Santos SR; Cukier A; Verrastro C; Carvalho-Pinto RM; Fiss E; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):170-2. PubMed ID: 1843714
[TBL] [Abstract][Full Text] [Related]
3. Oral doxophylline in patients with chronic obstructive pulmonary disease.
Villani F; De Maria P; Ronchi E; Galimberti M
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
[TBL] [Abstract][Full Text] [Related]
5. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
7. Salbutamol plus beclomethasone dipropionate versus theophylline for the prevention of methacholine-induced bronchospasm in patients with chronic bronchitis.
Arossa W; Spinaci S; Testi R
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):565-8. PubMed ID: 4066080
[TBL] [Abstract][Full Text] [Related]
8. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
9. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
Thomas P; Pugsley JA; Stewart JH
Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
[TBL] [Abstract][Full Text] [Related]
10. Theophylline in stable chronic airflow obstruction. A reappraisal.
Dull WL; Alexander MR
Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
[TBL] [Abstract][Full Text] [Related]
11. [Interactions of theophylline and nifedipine].
Luther R; Wichert H; Köhler E; Banditt P; Walther H
Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
[TBL] [Abstract][Full Text] [Related]
12. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
[TBL] [Abstract][Full Text] [Related]
13. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
[TBL] [Abstract][Full Text] [Related]
14. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
Filuk RB; Easton PA; Anthonisen NR
Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322
[TBL] [Abstract][Full Text] [Related]
15. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
16. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
17. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
Nishimura K; Koyama H; Ikeda A; Izumi T
Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
[TBL] [Abstract][Full Text] [Related]
18. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
Bossert J; Träger E
Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475
[TBL] [Abstract][Full Text] [Related]
19. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Taccola M; Bancalari L; Ghignoni G; Paggiaro PL
Monaldi Arch Chest Dis; 1999 Aug; 54(4):302-6. PubMed ID: 10546469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
